Evidence map›Paper›PMID 32049977›Full record

ArticlePloS one2020

The intracellular seven amino acid motif EEGEVFL is required for matriptase vesicle sorting and translocation to the basolateral plasma membrane.

Chun-Che Tseng, Bailing Jia, Robert B Barndt, Yang-Hong Dai, Yu Hsin Chen, Po-Wen A Du, Jehng-Kang Wang, Hung-Jen Tang, Chen-Yong Lin, Michael D Johnson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Chun-Che TsengLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, United States of America.
Bailing JiaLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, United States of America.
Robert B BarndtLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, United States of America.
Yang-Hong DaiDepartment of Radiation Oncology, Tri-Service General Hospital, Taipei, Taiwan.
Yu Hsin ChenSchool of Medicine, National Defense Medical Center, Taipei, Taiwan.
Po-Wen A DuLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, United States of America.
Jehng-Kang WangNational Defense Medical Center, Department of Biochemistry, Taipei, Taiwan.
Hung-Jen TangSection of Infectious Diseases, Chi-Mei Medical Center, Tainan, Taiwan.
Chen-Yong LinLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, United States of America.ORCID 0000-0002-6391-2571
Michael D JohnsonLombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, United States of America.
Georgetown University · USNational Defense Medical Center · TWChi Mei Medical Center · TWTri-Service General Hospital · TW

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI STEPHEN W BYERS · 1990 to 2026
$71.5M
Mechanisms of Deregulation of Matriptase in Breast CancerR01CA123223 · NCI · GEORGETOWN UNIVERSITY · PI JOHNSON, MICHAEL D, LIN, CHEN-YONG · 2010 to 2014
$1.6M
NCI NIH HHS P30 CA051008NCI NIH HHS R01 CA123223
6 · The paper itself

Abstract

Matriptase plays important roles in epithelial integrity and function, which depend on its sorting to the basolateral surface of cells, where matriptase zymogen is converted to an active enzyme in order to act on its substrates. After activation, matriptase undergoes HAI-1-mediated inhibition, internalization, transcytosis, and secretion from the apical surface into the lumen. Matriptase is a mosaic protein with several distinct protein domains and motifs, which are a reflection of matriptase's complex cellular itinerary, life cycle, and the tight control of its enzymatic activity. While the molecular determinants for various matriptase regulatory events have been identified, the motif(s) required for translocation of human matriptase to the basolateral plasma membrane is unknown. The motif previously identified in rat matriptase is not conserved between the rodent and the primate. We, here, revisit the question for human matriptase through the use of a fusion protein containing a green fluorescent protein linked to the matriptase N-terminal fragment ending at Gly-149. A conserved seven amino acid motif EEGEVFL, which is similar to the monoleucine C-terminal to an acidic cluster motif involved in the basolateral targeting for some growth factors, has been shown to be required for matriptase translocation to the basolateral plasma membrane of polarized MDCK cells. Furthermore, time-lapse video microscopy showed that the motif appears to be required for entry into the correct transport vesicles, by which matriptase can undergo rapid trafficking and translocate to the plasma membrane. Our study reveals that the EEGEVFL motif is necessary, but may not be sufficient, for matriptase basolateral membrane targeting and serves as the basis for further research on its pathophysiological roles.

Indexed as

Amino Acid MotifsAnimalsCell LineCell MembraneCell Membrane StructuresCell PolarityCytoplasmDogsEnzyme PrecursorsGreen Fluorescent ProteinsHEK293 CellsHumansMadin Darby Canine Kidney CellsMembrane GlycoproteinsProteinase Inhibitory Proteins, SecretoryProtein TransportEnzyme PrecursorsGreen Fluorescent ProteinsmatriptaseMembrane GlycoproteinsProteinase Inhibitory Proteins, SecretorySerine Endopeptidases

Identifiers

PMID32049977
PMCPMC7015431
OpenAlexW3006162945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.